Endometrial cancer (Q63199203)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16084259%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

review article

1 reference

title

Endometrial cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16084259%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

6

Ignace Vergote

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16084259%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

4

Dirk Timmerman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16084259%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1

Frederic Amant

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16084259%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

3

Patrick Neven

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16084259%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

Philippe Moerman

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16084259%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Erik Van Limbergen

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16084259%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

language of work or name

English

0 references

publication date

1 August 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16084259%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16084259%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

366

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16084259%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

9484

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16084259%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

491-505

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16084259%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Racial differences in endometrial cancer survival: the black/white cancer survival study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Endometrial cancer: socioeconomic status and racial/ethnic differences in stage at diagnosis, treatment, and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Effect of hysterectomy on incidence trends of endometrial and cervical cancer in Finland 1953-2010

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Anthropometry, Physical Activity, and Endometrial Cancer Risk: Results From The Netherlands Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

American Cancer Society guidelines for the early detection of cancer, 2003.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Endometrioid carcinoma of the uterine corpus: a review of its pathology with emphasis on recent advances and problematic aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Villoglandular adenocarcinoma of the endometrium: a clinicopathologic study of 61 cases: a gynecologic oncology group study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

The utility of the revised International Federation of Gynecology and Obstetrics histologic grading of endometrial adenocarcinoma using a defined nuclear grading system. A Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

A binary architectural grading system for uterine endometrial endometrioid carcinoma has superior reproducibility compared with FIGO grading and identifies subsets of advance-stage tumors with favorable and unfavorable prognosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Prognostic impact of histological grade and vascular invasion compared with tumour cell proliferation in endometrial carcinoma of endometrioid type

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Two pathogenetic types of endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Uterine papillary serous carcinoma: a study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Minimal uterine serous carcinoma: diagnosis and clinicopathologic correlation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Undifferentiated carcinoma of the endometrium. A histopathologic and clinical study of 31 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Serous endometrial cancers that mimic endometrioid adenocarcinomas: a clinicopathologic and immunohistochemical study of a group of problematic cases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Stage IA uterine serous carcinoma: a study of 13 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Endometrial intraepithelial carcinoma with associated peritoneal carcinomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Simultaneous presentation of carcinoma involving the ovary and the uterine corpus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Metastatic and independent cancers of the endometrium and ovary: a clinicopathologic study of 34 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

A molecular genetic and statistical approach for the diagnosis of dual-site cancers.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Global expression changes of constitutive and hormonally regulated genes during endometrial neoplastic transformation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Involution of PTEN-null endometrial glands with progestin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Progestin alone as primary treatment of endometrial carcinoma in premenopausal women. Report of seven cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

PTEN1 is frequently mutated in primary endometrial carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma: evidence of distinct molecular genetic pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

HER2/neu overexpression: has the Achilles' heel of uterine serous papillary carcinoma been exposed?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Gene expression profiles of human endometrial cancer samples using a cDNA-expression array technique: assessment of an analysis method

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Case-control study of endogenous steroid hormones and endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Risk factors among young women with endometrial cancer: a Danish case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Postmenopausal endogenous oestrogens and risk of endometrial cancer: results of a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Insulin-like growth factor-binding protein-1: a biochemical marker of endometrial response to progestin during hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Increased Circulating Levels of Insulin-Like Growth Factor-I and Decreased Circulating Levels of Insulin-Like Growth Factor Binding Protein-1 in Postmenopausal Women with Endometrial Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Insulin-like growth factor 1 is required for G2 progression in the estradiol-induced mitotic cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Steroid-modulated proliferation of human endometrial carcinoma cell lines: any role for insulin-like growth factor signaling?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Metabolic abnormalities (hypertension, hyperglycemia and overweight), lifestyle (high energy intake and physical inactivity) and endometrial cancer risk in a Norwegian cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Physical activity and risk of endometrial cancer in a prospective cohort study (United States).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Polycystic ovary syndrome and endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Effect of exercise on serum estrogens in postmenopausal women: a 12-month randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Association of Soy and Fiber Consumption with the Risk of Endometrial Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Phytoestrogen intake and endometrial cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Soya food intake and risk of endometrial cancer among Chinese women in Shanghai: population based case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Endometrial effects of long-term treatment with phytoestrogens: a randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Cigarette Smoking and the Risk of Endometrial Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Smoking and the risk of endometrial cancer: Results from the Nurses' Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Effects of Alcohol Ingestion on Estrogens in Postmenopausal Women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Alcohol consumption and endometrial cancer: some unresolved issues

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Grand multiparity and incidence of endometrial cancer: a population-based study in Finland

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Cancer risk associated with subfertility and ovulation induction: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Noncontraceptive health benefits of intrauterine devices: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Tubal sterilization and risk of ovarian, endometrial and cervical cancer. A Danish population-based follow-up study of more than 65 000 sterilized women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Oral contraceptives and reproductive system cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Endometrial safety of hormone replacement therapy: review of literature

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Endometrial cancer and hormone-replacement therapy in the Million Women Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Tibolone and endometrial cancer: a cohort and nested case-control study in the UK.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Association between uterine serous carcinoma and breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Longitudinal hysteroscopic follow-up during tamoxifen treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Guidelines for monitoring patients taking tamoxifen treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Overview of the main outcomes in breast-cancer prevention trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Does tamoxifen use affect prognosis in breast cancer patients who develop endometrial cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Tamoxifen therapy for breast cancer and endometrial cancer risk.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Identification of women at high risk of developing endometrial cancer on tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Endometrial pathologies associated with postmenopausal tamoxifen treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Molecular determinants for the tissue specificity of SERMs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Endometrial protection from tamoxifen-stimulated changes by a levonorgestrel-releasing intrauterine system: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Third generation aromatase inhibitors may prevent endometrial growth and reverse tamoxifen-induced uterine changes in postmenopausal breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Prevention of osteoporosis and uterine effects in postmenopausal women taking raloxifene for 5 years

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Development of endometrial cancer after radiation treatment for cervical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Familial clustering of ovarian and endometrial cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Hereditary factors in cancer. Study of two large midwestern kindreds

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Testing guidelines for hereditary non-polyposis colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Ultrasonographic detection of asymptomatic endometrial cancer in postmenopausal patients offers no prognostic advantage over symptomatic disease discovered by uterine bleeding.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Transvaginal ultrasonography compared with endometrial biopsy for the detection of endometrial disease. Postmenopausal Estrogen/Progestin Interventions Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Should tamoxifen users be screened for endometrial lesions?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Gynecologic cancer as a "sentinel cancer" for women with hereditary nonpolyposis colorectal cancer syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Laparoscopic prophylactic surgery for HNPCC gene mutation carrier: has the time come?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Histopathological findings in women with postmenopausal bleeding.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Predicting endometrial cancer among older women who present with abnormal vaginal bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Accuracy of outpatient endometrial biopsy in the diagnosis of endometrial cancer: a systematic quantitative review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Accuracy of outpatient endometrial biopsy in the diagnosis of endometrial hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Cost-effectiveness of the use of transvaginal sonography in the evaluation of postmenopausal bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Outpatient hysteroscopy and ultrasonography in the management of endometrial disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Ultrasonographic endometrial thickness for diagnosing endometrial pathology in women with postmenopausal bleeding: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Combining vaginal ultrasonography and office endometrial sampling in the diagnosis of endometrial disease in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Accuracy of hysteroscopy in the diagnosis of endometrial cancer and hyperplasia: a systematic quantitative review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Saline contrast hysterosonography in abnormal uterine bleeding: a systematic review and meta‐analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

The pedicle artery sign based on sonography with color Doppler imaging can replace second-stage tests in women with abnormal vaginal bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Does hysteroscopy produce intraperitoneal spread of endometrial cancer cells?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Impact of hysteroscopy on disease-free survival in clinically stage I endometrial cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Ultrasound assessment of endometrial thickness and endometrial polyps in women on hormonal replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Pap smears in women with endometrial carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Clinical value of intraoperative gross examination in endometrial cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

High frequency transvaginal ultrasonography in preoperative assessment of myometrial invasion in endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Radiologic staging in patients with endometrial cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Accuracy of intraoperative frozen-section diagnosis in stage I endometrial adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Preoperative CA 125 in endometrial cancer: is it useful?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

The new International Federation of Gynecology and Obstetrics surgical staging and survival rates in early endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Is there a difference in outcome between stage I-II endometrial cancer of papillary serous/clear cell and endometrioid FIGO Grade 3 cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

High-risk endometrial cancer subgroups: candidates for target-based adjuvant therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Endometrial adenocarcinoma in Norway. A study of a total population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Clinical stage I endometrial cancer: prognostic factors for local control and distant metastasis and implications of the new FIGO surgical staging system

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Is there a prognostic difference between depth of myometrial invasion and the tumor-free distance from the uterine serosa in endometrial cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Should the Presence of Lymphvascular Space Involvement Be Used to Assign Patients to Adjuvant Therapy Following Hysterectomy for Unstaged Endometrial Cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Prognostic parameters of endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Total laparoscopic hysterectomy as a primary surgical treatment for endometrial cancer in morbidly obese women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

High incidence of positive peritoneal cytology in low-risk endometrial cancer treated by laparoscopically assisted vaginal hysterectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Incidence of positive peritoneal cytology in low-risk endometrial cancer treated by laparoscopically assisted vaginal hysterectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Vaginal cuff recurrence of endometrial cancer treated by laparoscopic-assisted vaginal hysterectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Adenocarcinoma of the Endometrium: Survival Comparisons of Patients with and without Pelvic Node Sampling

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Retrospective Analysis of Selective Lymphadenectomy in Apparent Early-Stage Endometrial Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Staging quality is related to the survival of women with endometrial cancer: a Scottish population based study. Deficient surgical staging and omission of adjuvant radiotherapy is associated with poorer survival of women diagnosed with endometrial c

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Surgical stage IV endometrial carcinoma: a study of 47 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

The Role of Surgical Cytoreduction in Stage IV Endometrial Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Stage IVB endometrial carcinoma: the role of cytoreductive surgery and determinants of survival

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Uterine papillary serous carcinomas: the exigency for clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Uterine papillary serous carcinoma: comparisons of outcomes in surgical Stage I patients with and without adjuvant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Clear cell carcinoma of the endometrium. Prognosis and metastatic pattern

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

What staging surgery should be performed on patients with uterine papillary serous carcinoma?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

The role of cytoreductive surgery in the management of stage IV uterine papillary serous carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

FIGO stage III and IV uterine papillary serous carcinoma: impact of residual disease on survival

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

A systematic overview of radiation therapy effects in uterine cancer (corpus uteri).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Post-operative high dose rate brachytherapy in patients with low to intermediate risk endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Survival after relapse in patients with endometrial cancer: results from a randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Doxorubicin as an adjuvant following surgery and radiation therapy in patients with high-risk endometrial carcinoma, stage I and occult stage II: a Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

A new aggressive treatment approach to high-grade endometrial cancer of possible benefit to patients with stage I uterine papillary cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

A randomized trial of adjuvant progestagen in early endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

High-dose megestrol acetate in advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Phase II study of medroxyprogesterone acetate plus tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Adriamycin and cis-diamminedichloroplatinum in the treatment of metastatic endometrial adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Treatment of recurrent endometrial adenocarcinoma with a combination of doxorubicin and cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Circadian-timed combination doxorubicin-cisplatin chemotherapy for advanced endometrial carcinoma. A phase II study of the Gynecologic Oncology Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Phase II evaluation of carboplatin in advanced endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Treatment of advanced or recurrent endometrial carcinoma with single-agent carboplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a gynecologic oncology group study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Uterine papillary serous carcinoma (UPSC) treated with cisplatin, doxorubicin, and cyclophosphamide (PAC)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

The use of paclitaxel and platinum-based chemotherapy in uterine papillary serous carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Treatment of uterine papillary serous carcinoma with paclitaxel

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Paclitaxel and carboplatin, alone or with irradiation, in advanced or recurrent endometrial cancer: a phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021

Value and cost evaluation of routine follow-up for patients with clinical stage I/II endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967063-8

7 January 2021